Join our mailing list to receive the latest updates and alerts Flag Subscribe

Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, in its acquisition of B-MoGen Biotechnologies Inc. B-MoGen Biotechnologies Inc. translates the world’s most powerful genome editing technology into greatly needed products throughout the life sciences and based in Minneapolis.

Fredrikson’s legal team was led by Melodie Rose, Ryan Brauer, and Eldri Johnson.

Read the news release.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.